ULOQ [Study As­sess­ment]

posted by Anand – India, 2017-10-30 06:38  – Posting: # 17945
Views: 6,213

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,817 posts in 4,200 threads, 1,361 registered users;
online 10 (0 registered, 10 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 16:33 CEST

A big computer, a complex algorithm and a long time
does not equal science.    Robert Gentleman

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5